Skip to content
Pass Duke Elder
Textbook / Chapter 14 / Ocular pathology, genetics and systemic associations

Inheritance patterns and the genes worth knowing

Ophthalmology has more named single-gene diseases than almost any other specialty, and the Duke-Elder exam asks about them in two ways: work out the pattern from a family, or match a gene to its disease. This lesson teaches the four inheritance patterns with eye examples, the terms that explain why real families do not follow the textbook, the two-hit hypothesis, a table of genes to learn, and an outline of genetic testing and gene therapy in the UK.

10 minute read8 linked questions

The four patterns

A person has two copies of every gene on the 22 pairs of autosomes, one from each parent. Sex chromosomes differ: a woman has two X chromosomes and a man has one X and one Y. A separate small genome sits in the mitochondria and comes only from the mother, because the egg supplies the embryo's mitochondria. Those three facts generate the four patterns.

PatternWhat the family tree showsRisk to a childEye examples
Autosomal dominantEvery generation; both sexes; father to son transmission occurs1 in 2 from an affected parentRetinoblastoma, aniridia, Marfan syndrome, neurofibromatosis, dominant optic atrophy, Best disease, most corneal stromal dystrophies
Autosomal recessiveBrothers and sisters affected, parents healthy; more likely if the parents are related1 in 4 when both parents are carriersStargardt disease, oculocutaneous albinism, achromatopsia, Usher syndrome, macular corneal dystrophy
X-linked recessiveMales affected; passed through unaffected carrier females; never father to sonA carrier mother's sons: 1 in 2 affected. Her daughters: 1 in 2 carriersRed-green colour deficiency, X-linked retinitis pigmentosa, choroideremia, ocular albinism, X-linked retinoschisis
MitochondrialPassed down the female line only; both sexes can be affectedAll children of an affected mother inherit the mutation; none of an affected fatherLeber hereditary optic neuropathy
Inheritance patterns

In autosomal dominant disease one altered copy is enough. In autosomal recessive disease both copies must be altered, so the healthy parents are each carriers of one. The two altered copies need not carry the same mutation: a person with two different mutations in the same gene is a compound heterozygote, which is common in Stargardt disease.

X-linked recessive disease follows from men having a single X. A man with the mutation has no second copy to compensate. He gives his X to all his daughters, who are all carriers, and his Y to all his sons, who are all unaffected. Red-green colour deficiency is the everyday example: the genes for the red and green cone pigments lie on the X chromosome, so about 8% of men are affected against about 0.5% of women.

Why families do not follow the rules

Several terms describe the gap between having a mutation and showing a disease. They are often examined as definitions.

  • Penetrance is the proportion of people with the mutation who show any sign of the disease. Aniridia is completely penetrant. Heritable retinoblastoma is about 90% penetrant, so a few carriers never develop a tumour but can still pass the mutation on. Incomplete penetrance is one reason a dominant disease can appear to skip a generation.
  • Expressivity is how severely or in what form the disease appears in those who do show it. Variable expressivity is the rule in neurofibromatosis type 1 and in dominant optic atrophy, where acuity within one family can range from normal to very poor.
  • A de novo mutation is new in the affected person and present in neither parent, so there is no family history. This is common in dominant diseases such as neurofibromatosis type 1 and tuberous sclerosis.
  • Anticipation is onset at an earlier age and with greater severity in each generation. It occurs in diseases caused by an expanding run of three-base repeats. In myotonic dystrophy the repeat is CTG in the DMPK gene: a grandparent with a small expansion may have only cataract, while a grandchild with a large one is affected from infancy.
  • Mosaicism is the presence of two or more genetically different cell populations in one person, because a mutation arose after fertilisation. It can produce disease confined to one segment of the body.
  • Heteroplasmy is the mitochondrial equivalent: a cell holds many mitochondrial genomes, and only a proportion may carry the mutation.

Women are natural mosaics for the X chromosome. Early in the embryo each cell switches off one X at random, a process called lyonisation, and all its daughter cells keep the same choice. A woman who carries an X-linked eye disease therefore has patches of affected and unaffected retina. Carriers of choroideremia show patchy pigment atrophy, and carriers of X-linked ocular albinism show a mud-splattered fundus. Finding these signs in a mother confirms the pattern in her son.

The two-hit hypothesis

A tumour suppressor gene makes a protein that restrains cell division. One working copy is enough to do the job, so a cell must lose both copies before it escapes control. Alfred Knudson worked this out in 1971 from the ages at which children developed retinoblastoma, and the gene was later identified as RB1 on chromosome 13q14.

In heritable retinoblastoma the first hit is inherited or arises in the germline, so it is present in every retinal cell from the start. Only one more hit is needed, and among millions of dividing retinal cells that is likely to happen more than once. These children present younger, often with tumours in both eyes. In non-heritable retinoblastoma both hits must occur by chance in the same cell. This is rare, so the child has one tumour in one eye and presents later.

The hypothesis resolves an apparent contradiction. At the level of the cell RB1 is recessive, since both copies must be lost. At the level of the family the predisposition is inherited as an autosomal dominant trait, because one inherited mutation makes the second hit almost certain. The same logic applies to the other tumour suppressor genes in the table: NF1, NF2, VHL, TSC1 and TSC2.

Genes to learn

GeneLocationDiseaseInheritance
RB113q14RetinoblastomaAutosomal dominant predisposition
PAX611p13AniridiaAutosomal dominant
FBN115q21Marfan syndromeAutosomal dominant
NF117q11.2Neurofibromatosis type 1Autosomal dominant
NF222q12Neurofibromatosis type 2Autosomal dominant
VHL3p25Von Hippel-Lindau diseaseAutosomal dominant
TSC1 and TSC2Chromosomes 9 and 16Tuberous sclerosisAutosomal dominant
ABCA41p22Stargardt diseaseAutosomal recessive
RHOAutosomalRetinitis pigmentosa (rhodopsin)Autosomal dominant
RPGRX chromosomeRetinitis pigmentosaX-linked
OPA13q28-q29Dominant optic atrophyAutosomal dominant
MT-ND1, MT-ND4, MT-ND6Mitochondrial DNALeber hereditary optic neuropathyMitochondrial
RPE65AutosomalLeber congenital amaurosis and early retinal dystrophyAutosomal recessive
Key genes in ophthalmology

A few of these deserve a sentence of mechanism, because the mechanism is what makes them memorable.

PAX6 is a master control gene for eye development. Losing one copy gives aniridia: a rudimentary iris, an underdeveloped fovea with nystagmus, and later cataract, glaucoma and corneal surface failure. About two thirds of cases are familial. In sporadic cases the cause may be a deletion that also removes the neighbouring WT1 gene, producing WAGR syndrome (Wilms tumour, aniridia, genitourinary anomalies and intellectual disability), so a baby with sporadic aniridia is tested for the deletion because of the risk of Wilms tumour.

ABCA4 encodes a transporter in the outer segment discs of photoreceptors that clears a by-product of the visual cycle. Without it the by-product is converted to a toxic vitamin A dimer that accumulates as lipofuscin in the retinal pigment epithelium. The result is Stargardt disease, the commonest inherited macular dystrophy of childhood, with yellow flecks, central visual loss and, on fluorescein angiography, a dark choroid in many patients. Patients are advised not to take vitamin A supplements.

Retinitis pigmentosa is caused by many genes and can follow any pattern. Mutations in RHO, the gene for rhodopsin, are a frequent cause of the dominant form, and RPGR of the X-linked form. X-linked disease is the most severe and dominant disease the mildest.

Leber hereditary optic neuropathy is caused by point mutations in mitochondrial genes for complex I of the respiratory chain. Three account for most cases: 11778 in MT-ND4, which is the commonest, 3460 in MT-ND1, and 14484 in MT-ND6, which has the best chance of visual recovery. Penetrance is incomplete and strikingly unequal: about half of male carriers lose vision against about one in ten female carriers, so most affected patients are male, for reasons not fully explained. OPA1, by contrast, is a nuclear gene whose protein maintains the inner mitochondrial membrane. Its mutations cause dominant optic atrophy, a slow bilateral loss of central vision from childhood with pallor of the temporal side of the disc. Both diseases are taught in the neuro-ophthalmology chapter.

Genetic testing and gene therapy

In England genetic testing is provided through the NHS Genomic Medicine Service, and the National Genomic Test Directory sets out which test is available for which condition, from single genes to whole genome sequencing. For an inherited retinal dystrophy a panel of many genes is tested at once, because different genes produce the same clinical picture. A molecular diagnosis confirms the inheritance pattern, allows relatives to be tested and counselled, informs prognosis, and decides eligibility for treatment. Testing a child or a healthy relative has consequences for the whole family, so it is done with genetic counselling.

The retina is well suited to gene therapy. It is small, accessible by surgery, enclosed, and immune privileged. In gene supplementation a harmless virus, usually an adeno-associated virus, carries a working copy of the gene into the target cells. This suits recessive diseases, in which the cell simply lacks a working copy.

The first licensed example is voretigene neparvovec, which delivers the RPE65 gene by injection under the retina. NICE recommends it (HST11, 2019) for people with vision loss from inherited retinal dystrophy caused by confirmed mutations in both copies of RPE65 who have sufficient viable retinal cells. The last condition is general to gene therapy: it can rescue cells that are alive but cannot replace cells that have died, so the diagnosis must be made early.

Mitochondrial disease is harder to treat by gene transfer. For Leber hereditary optic neuropathy NICE recommends idebenone as an option for people aged 12 and over (TA1093, 2025), while noting that the evidence for benefit is uncertain. Gene therapy delivering MT-ND4 by intravitreal injection has been tested in trials.

Summary

  • Autosomal dominant disease appears in every generation with a 1 in 2 risk; autosomal recessive disease affects siblings of healthy carrier parents with a 1 in 4 risk.
  • X-linked recessive disease affects males through carrier females and is never passed from father to son.
  • Mitochondrial disease is passed only by mothers, to all their children.
  • Penetrance is whether the disease shows at all; expressivity is how severely; anticipation is earlier and worse disease in each generation.
  • Lyonisation makes female carriers of X-linked eye disease mosaics, with patchy fundus signs.
  • The two-hit hypothesis: both copies of a tumour suppressor gene must be lost; in heritable retinoblastoma the first hit is in every cell.
  • RB1 is on 13q14, PAX6 (aniridia) on 11p13, FBN1 (Marfan) on 15q21 and NF1 on 17q11.2.
  • ABCA4 causes autosomal recessive Stargardt disease; RHO and RPGR cause dominant and X-linked retinitis pigmentosa.
  • Leber hereditary optic neuropathy is mitochondrial (MT-ND4 11778 commonest); dominant optic atrophy is due to the nuclear gene OPA1.
  • Voretigene neparvovec is subretinal gene therapy for retinal dystrophy with mutations in both copies of RPE65.

Check yourself

Quick recall on this lesson. These are easier than the question bank.

1. A disease is passed by affected mothers to all their children and never by affected fathers. What is the inheritance pattern?
2. Mutation of which gene causes aniridia?
3. What does the term penetrance describe?
4. Which gene is replaced by voretigene neparvovec?
Practise 8 questions on this lesson

Written for revision. It is not a source of clinical advice, and guidance changes.